Swiss Market Report
August 29, 2019 / 4:22 PM / 3 months ago

BRIEF-Sandoz says Voluntarily Recalls Losartan Potassium, Ezetimibe In Prescription Drug Bottles In U.S.

1 Min Read

Aug 29 (Reuters) - SANDOZ INC:

* SANDOZ INC. VOLUNTARILY RECALLS LOSARTAN POTASSIUM AND EZETIMIBE IN PRESCRIPTION DRUG BOTTLES IN THE U.S. DUE TO FAILURE TO MEET CHILD-RESISTANT CLOSURE REQUIREMENTS

* SANDOZ INC - THERE ARE NO QUALITY OR SAFETY ISSUES WITH MEDICINES FOR THEIR INTENDED USE Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below